Advanced application of bovine intestinal epithelial cell line for evaluating regulatory effect of lactobacilli against heat-killed enterotoxigenic Escherichia coli-mediated inflammation
- Naoya Takanashi†1,
- Yohsuke Tomosada†1,
- Julio Villena†1, 2,
- Kozue Murata1,
- Takuya Takahashi1,
- Eriko Chiba1,
- Masanori Tohno1, 3,
- Tomoyuki Shimazu1, 4,
- Hisashi Aso5,
- Yoshihito Suda6,
- Shuji Ikegami7,
- Hiroyuki Itoh7,
- Yasushi Kawai1,
- Tadao Saito1,
- Susana Alvarez2 and
- Haruki Kitazawa1Email author
© Takanashi et al.; licensee BioMed Central Ltd. 2013
Received: 25 November 2012
Accepted: 4 March 2013
Published: 7 March 2013
Previously, a bovine intestinal epithelial cell line (BIE cells) was successfully established. This work hypothesized that BIE cells are useful in vitro model system for the study of interactions of microbial- or pathogen-associated molecular patterns (MAMPs or PAMPs) with bovine intestinal epithelial cells and for the selection of immunoregulatory lactic acid bacteria (LAB).
All toll-like receptor (TLR) genes were expressed in BIE cells, being TLR4 one of the most strongly expressed. We demonstrated that heat-stable PAMPs of enterotoxigenic Escherichia coli (ETEC) significantly enhanced the production of IL-6, IL-8, IL-1α and MCP-1 in BIE cells by activating both NF-κB and MAPK pathways. We evaluated the capacity of several lactobacilli strains to modulate heat-stable ETEC PAMPs-mediated inflammatory response in BIE cells. Among these strains evaluated, Lactobacillus casei OLL2768 attenuated heat-stable ETEC PAMPs-induced pro-inflammatory response by inhibiting NF-κB and p38 signaling pathways in BIE cells. Moreover, L. casei OLL2768 negatively regulated TLR4 signaling in BIE cells by up-regulating Toll interacting protein (Tollip) and B-cell lymphoma 3-encoded protein (Bcl-3).
BIE cells are suitable for the selection of immunoregulatory LAB and for studying the mechanisms involved in the protective activity of immunobiotics against pathogen-induced inflammatory damage. In addition, we showed that L. casei OLL2768 functionally modulate the bovine intestinal epithelium by attenuating heat-stable ETEC PAMPs-induced inflammation. Therefore L. casei OLL2768 is a good candidate for in vivo studying the protective effect of LAB against intestinal inflammatory damage induced by ETEC infection or heat-stable ETEC PAMPs challenge in the bovine host.
KeywordsBovine intestinal epithelial cells Immunobiotic ETEC PAMPs TLRs negative regulators Lactobacillus casei OLL2768
Enterotoxigenic Escherichia coli (ETEC) are pathogenic bacteria that are able to infect humans and several species of animals. In farm animals such as cattle, ETEC infection results in reduced growth rate, increased mortality and economic loss . ETEC interacts with intestinal epithelial cells (IECs), colonizes the small intestine and secretes enterotoxins inducing intestinal acute diarrhea and inflammation [2, 3]. In addition to its capacity to infect cells and induce damage through toxins, ETEC are able to induce an inflammatory response through other pathogen-associated molecular patterns (PAMPs) such as lipopolysaccharide (LPS) that contribute to cellular and tissue damage during infections [2, 4]. ETEC is able to trigger toll-like receptor (TLR)-4 activation and cytokines production by IECs and induce the recruitment and activation of inflammatory cells. Although this mechanism represent an important primary line of host defense, a prolonged or non-regulated pro-inflammatory cytokines production may lead to tissue damage and epithelial barrier disfunction [1, 4, 5]. Therefore, during ETEC infection it is imperative to generate an adequate inflammatory response against the pathogen, accompanied by efficient regulation, in order to achieve protection without damaging host tissues.
Probiotics have been defined as “live microorganisms which when administered in adequate amounts confer a health benefit on the host” . Several lactic acid bacteria (LAB) strains are considered beneficial to the host and as such have been used as probiotics and included in several functional foods. Modulation of host immunity is one of the most commonly alleged benefits of the consumption of probiotics. The term immunobiotics has been proposed for those probiotic strains with immunoregulatory activities . Studies have shown that immunobiotics can beneficially modulate the immune response against ETEC [8–11]. Roselli et al. showed that Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response caused by ETEC K88 by partly reducing pathogen adhesion and by counteracting neutrophil migration. Moreover, experiments in Caco-2 cells demonstrated that L. rhamnosus GG is able to counteract the ETEC-induced up-regulation of interleukin (IL)-1β and tumor necrosis factor (TNF), and the down-regulation of transforming growth factor β1 (TGF-β1) expression, and consequently to block the cytokine deregulation . In addition, comparative studies between L. rhamnosus GG and B. animalis MB5, demonstrated that individual strains of probiotics have a different impact on the inflammatory response triggered in IECs . Others studies evaluating the effect of probiotic yeasts showed that Saccharomyces cerevisiae CNCM I-3856 decreased the expression of pro-inflammatory mediators IL-6, IL-8, CCL20, CXCL2, CXCL10 in porcine intestinal epithelial IPI-2I cells cultured with F4+ ETEC . Moreover, it was demonstrated that the CNCM I-3856 strain inhibits ETEC-induced expression of pro-inflammatory cytokines and chemokines transcripts and proteins and that this inhibition was associated to a decrease of ERK1/2 and p38 mitogen-activated protein kinases (MAPK) phosphorylation and to an increase of the anti-inflammatory peroxisome proliferator-activated receptor-γmRNA level .
There is increasing research in the use of probiotics for decreasing pathogen load and ameliorating gastrointestinal disease symptoms in animals [12–15]. Several studies were conducted in vivo utilizing different probiotic strains to evaluate the effect of immunobiotics against ETEC infection, however the majority of these studies were performed in swine and only few in the cattle . Beside the in vivo studies, several in vitro tests can be performed to identify the best potential probiotics. In this sense, we have recently demonstrated that the combination of the nuclear factor κ B (NF-κB)-reporter assay using a porcine TLR2-expressing transfectant (HEKpTLR2 system), the mitogenic assay using porcine Peyer’s patches immunocompetent cells and the evaluation of anti-inflammatory activities of LAB in porcine intestinal epithelial (PIE) cell line are useful tools to select potential probiotic strains . Moreover, we showed that PIE cells can be used to study the mechanisms involved in the protective activity of immunobiotics against intestinal inflammatory damage and may provide useful information for the development of new immunologically functional feeds that help to prevent inflammatory intestinal disorders, including weaning-associated intestinal inflammation in pigs [14, 15]. Therefore the use of probiotics in animal feeding could be enhanced by preliminarly in vitro screening such as the production of inhibitory substances, survival in the gastrointestinal tract and antibiotic susceptibility  that can be analyzed to evaluate functionality and safety . Moreover, the use of probiotics in cattle could be improved by the development of in vitro systems specific for cattle that allow the simply and efficient assess of the immunomodulatory activity of the potential probiotic LAB strains.
Recently we have successfully established a bovine intestinal epithelial cell line (BIE cells) . We hypothesized that BIE cells are useful in vitro model system for the study of interactions between pathogens and bovine IECs, for the selection of immunobiotic microorganisms and for the study of the mechanisms of immunomodulation by probiotic LAB in IECs. Therefore, the aims of the present study were: i) to assess the capability of BIE cells to respond to the challenge with heat-stable ETEC PAMPs, considering the production of cytokines and the activation of MAPK and NF-κB pathways and; i) to select potential immunomodulatory LAB that may be used to beneficially modulate the inflammatory response in bovine IECs challenged with heat-stable ETEC PAMPs.
The bovine intestinal epithelial cell line (BIE cells) was originally derived from fetal bovine intestinal epitheliocytes, and then established as a SV40 large T antigen-transformed intestinal cell line as previously described . BIE cells were maintained in Dulbecco’s modified Eagle medium (DMEM; GIBCO, Grand Island, NY) containing 10% heat-inactivated fetal bovine serum (FBS) and penicillin-streptomycin until it they were used for further studies. For the passage, BIE cells were treated with a sucrose/EDTA buffer (0.1M Na2HPO4/12H2O, 0.45M Sucrose, 0.36% EDTA/4Na, BSA) for 4 min, detached using 0.04% trypsin in phosphate-buffered saline (PBS, pH7.2) . Then, BIE cells were plated in collagen type I-coated culture dishes (Sumilon, Tokyo, Japan) at 1.5×104 cells/cm2 and cultured at 37°C in an atmosphere of 5% CO2 in Dulbecco’s Modified Eagle media (DMEM) (10% FCS, 1% streptomycin/penicillin, 100 U/ml streptomycin, high glucose, L-glutamine, 0.11 mg/ml sodium pyruvate; GIBCO).
Enterotoxigenic Escherichia coli (ETEC) strain 987 (O9: H-: 987P+: STa+) was kindly provided by Dr. M. Nakazawa, National Institute of Animal Health (Tsukuba, Japan) . ETEC cells were grown in blood agar (5% sheep blood) for 24 hours at 37°C and then transferred to tryptic soy broth (TSB; Becton, Dickinson and Company, USA) for 5 days at 37°C without shaking to get a pellicle containing piliated phase. ETEC cells were collected from the pellicle and transferred to 1L TSB and cultured 20 hours at 37°C with shaking. After incubation, the subcultures of bacteria were centrifuged at 5000 × g for 10 min at 4°C and washed with PBS (pH7.2). Finally, ETEC cells were heat killed at 100°C for 15 minutes and then washed with PBS. Heat-stable ETEC PAMPs were suspended in DMEM for use. The following lactobacilli strains were used in this study: Lactobacillus reuteri MEP221101 and MEP221102, Lactobacillus casei MEP221103, OLL2768, MEP221104, MEP221105, MEP221106, MEP221107, MEP221108, MEP221109, MEP221114 and MEP221115, Lactobacillus rhamnosus MEP221110, MEP221111, MEP221112 and GG, Lactobacillus salivarius MEP221113, Lactobacillus jensenii TL2937 and Lactobacillus gasseri MEP221117. The lactobacilli strains were grown in de Man, Rogosa and Sharpe (MRS) medium (Difco, Detroit, USA) for 16 h at 37°C and washed with PBS (pH7.2), and heat killed (60°C, 30 min). These bacterial samples were resuspended in DMEM, enumerated using a Petroff-Hausser counting chamber, and stored at −80°C until use .
BIE cells were cultured at a cell density of 3×104 cells/well of a 12-well culture plate collagen type I-coated glass disk (Iwaki Glass Co., Tokyo, Japan) for 3 days, (37°C, 5% CO2). BIE cells were washed with cold PBS (pH7.2) plus 2% FCS twice and then fixed with 4% paraformaldehyde/PBS solution (room temperature, 5 minutes). Following treating with PBS-T (0.2% Triton X-100) for 5 min at room temperature and washing three times with PBS. Cells were then incubated with Alexa 488 conjugated rabbit anti-TLR2 polyclonal antibody (bs-1019R-Alexa488, Bioss Inc., Wobum, MA, USA) or Alexa 488 conjugated rabbit anti-TLR4 antibody (bs-1021R-Alexa488, Bioss) diluted 50 times with Can Get Signal solution 1 (NKB-201, TOYOBO Co., Ltd., Osaka, Japan) overnight at 4°C. Both anti-TLR2 and anti-TLR4 antibodies cross-react with bovine receptors according to Bioss Inc. datasheet. Alexa 488 conjugate rabbit IgG (20304AF488, IMGENEX, San Diego, CA, USA) was used as isotype control. Following washing three times with PBS-T and the cells were rinsed in distilled water and then mounted with FLUOROSHIELD with DAPI (AR-6501-01, ImmunoBioScience Corp, Mukilteo, WA, USA). Immunofluorescence microscopy was performed with using a confocal laser microscope (LSM 700, Carl Zeiss, Oberkochen, Germany).
Quantitative expression analysis of toll-like receptors by real-time polymerase chain reactions (PCR) in BIE cells
Primer sequences used in this study
TGG ATT GGC GGC TCC AT
GCT GAT CCA CAT CTG CTG GAA
CAT TCC TAG CAG CTA CCA CAA GCT
TGG GCC ATT CCA AAT AAG TTC T
GGG TGC TGT GTC ACC GTT TC
GCC ACG CCC ACA TCA TCT
GGG CAC CTG GAG GTC CTT
TTC CTG GCC TGT GAG TTC TTG
AGC ACC TAT GAT GCC TTT GTC A
GTT CAT TCC GCA CCC AGT CT
GTC CCC AAC ACC ACC AAG AG
GCG GTT GTG ACT GTC CTG ATA TAG
TTT ACC CTC AAC CAC GTG GAA
GGG CCA AAG GAA CTG AAA AAC
CAC CAA CCT TAC CCT CAC CAT T
GTC CAG CCG GTG AAA GGA
TGT GTT TAG AGG AAA GGG ATT GG
TCT GCA TGA GGT TGT CGA TGA
CAG TGG CCA GGG TAG TTT CTG
CCG GTT ATA GAA GTG ACG GTT GT
TCT ACT GCA TCC CTA CCA GAT ATC C
GGG CCA TTC CAA GTA TGC TTT
CAC CAG CAG CAA GTG TCC TAA A
CAC ATA ACT CCT TGC CCA GGA T
CGC ATT GCA GTC TCC TAC CA
GGG CTC TTG ATG GCA GAC A
CGT GGA GCT GTA CCA GAA ATA TAG C
CGA GCA GCC GGT TGC T
GGT GGC AGC CAG TTA CAG AAG
TGC TGG GTC ACC TCA TGG A
CGA TGG TTC TCC TGC TGT GTT
GAG CAA GCT GTA GCT CCT GGA A
GGA GGA CTT CAA AAA GCT GAT TCA
GGC TTT GCG CTG GAT CTG
CTG TCC CAG CAA CCT CAT GA
TGG CAC TGC TGT TGA GTT GTC
CAG TTG CCC ATC CAA AGT TGT T
TGC CAT GTG CAC CAA TTT TT
GAG CCT GTC ATC TTC GAA ACG
GCA CGG GTG CGT CAC A
GCC ACA CGT GCT TGA ACA AA
TGC CAA GCT GTT GAG ATT CCT
CCA CCC CAG GCA GAC TAC TTC
CCA TGC GCT TAA TGA GAG CTT
CAA GCT TCA CCT ATC AAC AGT TTC A
CCC TTG CTG GTG CAG TTC A
TGC TCT CTT GGC AGC TTT CC
TCT TGA CAG AAC TGC AGC TTC AC
GGC GGT GGA GAA GGT GAA
GGC TTT GTA GAC ACC CCT CTC TT
CAG CAA GCC CAG GAA GGA
TGA CAG CCC TCA GCA GGT TT
Anti-inflammatory assay in BIE cells
Lactobacilli were re-suspended in DMEM (10% FCS, 1% SP), enumerated in a microscope using a Petroff-Hausser counting chamber, and stored at −80°C until use. BIE cells were plated at 3×104 cells/well of a 12-well ptype I collagen-coated plates (Iwaki, Tokyo, Japan), and cultured for three days. After changing medium, lactobacilli (5×107 cells/ml) were added and 48 hours later, each well was washed vigorously with medium at least 3 times to eliminate all the stimulants. Expression of cytokines, chemokines and TLRs negative regulators were studied first without any inflammatory challenge by using real time PCR as described below. In addition, the effect of lactobacilli on BIE cells immune response was studied using heat-stable ETEC as inflammatory factor. BIE cells were treated with heat-stable ETEC (final concentration: 5×107 cells/ml) for indicated time and the expression of cytokines, chemokines and TLRs negative regulators were studied by using real time PCR as described below. In addition, activation of p38, c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) mitogen-activated protein kinases and NF-кB pathways were studied by using western blotting as described below. In these experiments, the synthetic TLR2 agonist tripalmitoylated lipopeptide Pam3CysSerLys4 (Pam3CSK4) was also used. BIE cells were stimulated with Pam3CSK4 (final concentration: 200 ng/ml) for the indicated time same as the other stimuli.
Quantitative expression analysis of cytokines, chemokines and TLRs negative regulators by PCR in BIE cells
Two-step real-time quantitative PCR was used to characterize the expression of cytokines, chemokines and TLRs negative regulators mRNAs in BIE cells. Total RNA from each sample was isolated from the BIE cells using TRIzol reagent (Invitrogen). All cDNAs were synthesized from 5 μg of total RNA using a Quantitect Reverse Transcription kit (Qiagen, Tokyo, Japan) according to the manufacturer’s recommendations. Real-time quantitative PCR was carried out using a 7300 Real-time PCR System (Applied Biosystems, Warrington, UK) using Platinum SYBR Green qPCR SuperMix UDG with ROX (Invitrogen). The primers for cytokines, chemokines and TLRs negative regulators used in this study are described in Table 1. The PCR cycling conditions were 5 min at 50°C; followed by 5 min at 95°C; then 40 cycles of 15 sec at 95°C, 30 sec at 60°C and 30 sec at 72°C. The reaction mixture contained 5 μl of the sample cDNA and 15 μl of the master mix including the sense and antisense primers. Expression of β-actin was used to normalize cDNA levels for differences in total cDNA levels in the samples. TLRs mRNA levels in BIE cells were calibrated by the bovine β-actin level, and normalized by common logarithmic transformation in comparison to the each control (as 1.00).
Enzyme linked immunosorbent assay (ELISA) for the detection of cytokines
BIE cells were stimulated with L. casei OLL2768 or MEP221108 (5×107 cells/ml) for 48 hr and then challenged with heat-stable ETEC PAMPs as described before. The concentration of IL-6 and MCP-1 secreted into the supernatant of BIE cell cultures was determined using two commercially available enzyme- linked immunosorbent assay (ELISA) kits (bovine IL-6 [ESS0029, Thermo Scientific, Rockford, IL, USA] and bovine CCL2/MCP-1 [E11-800, Bethyl Laboratories, Inc. Montgomery, TX, USA]), according to the manufacturers’ instructions.
BIE cells cultured in 1.8×105 cells/60 mm dishes were stimulated with Lactobacillus casei OLL2768 or Pam3CSK4 with same time schedule and equivalent amount as mentioned above. BIE cells were then washed and stimulated with heat-stable ETEC PAMPs for indicated time. After stimulation, BIE cells were washed three times with PBS and resuspended in 200 μl of CelLytic M Cell Lysis Reagent (Sigma-Aldrich, St. Louis, MO, USA) including protease and phosphates inhibitors (complete Mini, PhosSTOP: Roche, Mannheim, Germany). Protein concentration was measured with BCA protein assay kit (Pierce, Rockford, IL, USA). Extracts (120 μl) were transferred into Eppendorf tubes and were added with 40 μl of Sample Buffer Solution (2ME+)(×4)(Wako), and boiled for 5 min at 95°C. Equal amounts of extracted proteins (2 μg) were loaded on 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Separated proteins were transferred electrophoretically to a PVDF membrane. The membrane was blocked with 2% BSA/TBS-T (w/v) for 2 hours at room temperature. Phosphorylation of p38, JNK and ERK mitogen-activated protein kinases and nuclear factor kappa B inhibitor protein (IkB) degradation were evaluated using Phospho-p38 MAPK (Thr180/Tyr182) antibody (p-p38, Cat. #9211); p38 MAPK antibody (p38, Cat. #9212); Phospho-SAPK/JNK (Thr183/Tyr185) antibody (p-JNK, Cat. #9251); SAPK/JNK antibody (JNK, Cat. #9252); Phospho-p44/42 MAP kinase (Thr202/Thy204) antibody (p-ERK, Cat. #9101); p44/42 MAP (Erk 1/2) antibody (ERK, Cat. #9102) and; I kappaB-alpha antibody (IkBa, Cat. #9242) from Cell Signaling Technology (Beverly, MA, USA) at 1000 times dilution of their original antibodies and with immunoreaction enhancer (Can Get Signal® Solution 1, TOYOBO Co. Ltd., Osaka, Japan) overnight at room temperature. After washing with TBS-T, the membrane was incubated alkaline phosphatase conjugated anti-rabbit IgG (Cat. #A3937, Sigma) at 2000 times dilution with immunoreaction enhancer (Can Get Signal® Solution 2, TOYOBO Co. Ltd., Osaka, Japan) for 1 hour at room temperature. After washing with TBS-T, signals were generated by overlaying the membrane with ECFTM substrate (GE Healthcare, Piscataway, NJ, USA) for 5 min at room temperature under dark conditions. The Attophos (Ex; 440nm, Em; 560nm) was detected by Molecular Imager Fx (Bio-Rad, Hercules, CA, USA). The densitometry of western blots was carried out by using Image J software (National Institutes of Health, Bethesda, MD, USA).
Z(xi): all adjusted data; xi: ith experimental data, x(control): a mean of repeated control data; and σx was a standard deviation of repeated control or trial data. Similarly, normalized relative expression for heat-stable ETEC PAMPs and lactobacilli data was fitted to this function to show them as a fold value compared to the control data. Each of data number repeated in a same condition was from 8 to 10. Statistical analysis was performed by using SAS computer program, ver.6.0 and GLM procedure. The multiple comparisons among means of fold expression were carried out by Fisher’s least significance differential test, LSD method. Differences were significant at 5% level and were showed in graphs with superscripts letters (for differences between means) or asterisks (for differences between each treatment a control).
Expression of TLRs in BIE cells
Study of the inflammatory response in BIE cells stimulated with heat-stable ETEC PAMPs
Selection of lactobacilli strains able to modulate inflammatory response in BIE cells
These results indicate that it is possible to modulate the inflammatory response in BIE cells by using LAB. Then, we next aimed to evaluate the potential anti-inflammatory effect of 20 lactobacilli strains in BIE cells with the aim of finding the strain with the highest immunomodulatory capacity in the bovine system. First, we evaluated the effect of lactobacilli on BIE cells without any inflammatory challenge (Additional file 1: Figure S1A). BIE cells were treated with the different lactobacilli strains for 48 h and the levels of mRNA IL-6, IL-8 and MCP-1 were determined. Only the strain MEP221102 slightly increased levels of MCP-1, and MEP221108 and MEP221114 also slightly increased levels of IL-6 in BIE cells (Additional file 1: Figure S1A). On the contrary, several strains were able to significantly down-regulate the levels of IL-8 in BIE cells (Additional file 1: Figure S1A). Next, we evaluated the effect of lactobacilli on BIE cells using heat-stable ETEC PAMPs as inflammatory factor (Additional file 1: Figure S1B). For this purpose, BIE cells were stimulated with the different LAB strains for 48 h, challenged with heat-stable ETEC PAMPs and the levels of the three pro-inflammatory cytokines were studied at hour 12 post-stimulation. MCP-1, IL-6 and IL-8 levels in BIE cells stimulated with OLL2768, MEP221101, MEP221105 and MEP221111 strains were significantly lower than those observed in the control. On the contrary, the other strains tested reduced one of the cytokines studied or had no effect (Additional file 1: Figure S1B). Considering that L. casei OLL2768 and L. casei MEP221111 showed the highest capacity to down-regulate IL-8 and also were able to reduce IL-6 and MCP-1 after heat-stable ETEC PAMPs challenge, one of these strains (L. casei OLL2768) was selected for the following experiments. To further confirm the immunoregulatory effect of L. casei OLL2768 and to obtain transcriptional data supported by protein detection of selected cytokines, we conducted ELISAs to evaluate the levels of IL-6 and MCP-1 proteins (Figure 3B). BIE cells were stimulated with L. casei OLL2768 or L. casei MEP221108 (negative control) and 48 h after were challenged with heat-stable ETEC PAMPs. Challenge significantly increased levels of both IL-6 and MCP-1 proteins. Pretreatment of BIE cells with L. casei OLL2768 significantly reduced levels of MCP-1, however L. casei MEP221108 was not able to modify MCP-1 values (Figure 3B). Both L. casei OLL2768 and MEP221108 were able to reduce levels of IL-6 after the challenge with heat-stable ETEC PAMPs, however the effect of L. casei OLL2768 was significantly higher than those observed for MEP221108. In addition, we evaluated if the TLR2 agonist Pam3CSK4 was able to modulate IL-6 and MCP-1 synthesis. BIE cells pretreated Pam3CSK4 showed reduced levels of both cytokines after heat-stable ETEC PAMPs challenge (Figure 3B).
Effect of L. casei OLL2768 on MAPK and NF-κB pathways in BIE cells
Effect of L. caseiOLL2768 on negative regulators of the TLRs signaling pathway in BIE cells
Although once considered simply a physical barrier, it is becoming increasingly evident that the epithelium plays as a crucial regulator of intestinal immune homeostasis. In response to invasive bacteria, IECs may produce a variety of cytokines and chemokines that play a crucial role in both the innate and adaptive immune responses in the gut . In this paper, in order to understand the functional role of the bovine intestinal epithelium in mucosal host defense as part of the immune system, we studied in BIE cells the expression of TLRs and characterized heat-stable ETEC PAMPs-induced signal transduction pathways and cytokine induction. It is known that IECs are able to respond to pathogenic microorganisms because their expression of pattern recognition receptors (PRRs) such as TLRs. Therefore, the first aim of our research was to investigate the expression of TLRs in BIE cells. We found that TLR4 was one of the most highly expressed TLRs in BIE cells. TLR4 is conserved among different species and its expression appears to be a characteristic feature of IECs , therefore, the presence of TLR4 in BIE cells resembles IECs of other species.
The inflammatory response triggered by the activation of TLR4 in IECs play a critical role in host defense against Gram(−) pathogens. In this study, we showed that heat-stable ETEC PAMPs from strain 987P significantly enhanced the production of IL-6, IL-8, IL-1α and MCP-1 in BIE cells by activating both NF-κB and MAPK pathways. These findings correlate with our previous observations since we demonstrated that the heat-killed ETEC 987P strain, which does not express flagellin, triggers a TLR4-mediated inflammatory response in porcine intestinal epithelial cells through its LPS . Moreover, the findings of the present work correlate with studies of the immune response against ETEC in IECs of different hosts species. It was shown that both NF-κB and MAPK pathways are important mediators of ETEC and LPS activation in human (HT29 and T84), mouse (CMT93) and porcine (PIE) IECs [14, 22].
The cytokines produced by BIE cells may have an important protective role during ETEC infection. The enhanced secretion of IL-8 stimulates the strong infiltration of neutrophils in the lamina propria that is observed upon ETEC infection. Following IL-8 induced recruitment of neutrophils IL-6 can induce degranulation of these cells, thereby enhancing the inflammatory response . On the other hand, IECs are able to produce MCP-1 in response to ETEC challenge. This chemokine has potent monocytes-activating and attracting propierties and plays a major role during intestinal inflammation . Therefore, our findings indicate that BIE cells are useful cell line for studying inflammatory responses via TLR4 in vitro. Moreover, taking into consideration that inflammatory responses induced by intestinal pathogens can lead to dysregulation of IECs signaling, disruption of membrane barrier integrity, enhancement of pathogen translocation and disease , BIE cells could be also used to evaluate therapies designed for preventing inflammatory damage caused by heat-stable ETEC PAMPs during ETEC infection.
Several reports have demonstrated that immunobiotic LAB are able to improve resistance against pathogens and to protect against inflammatory damage caused by the infectious process [25–27]. Therefore we next aimed to evaluate if an immunobiotic lactobacillus strain could regulate the inflammatory response induced by heat-stable ETEC PAMPs in BIE cells. Our laboratory has recently found that L. jensenii TL2937 has a high capacity to down-regulate IL-6 and IL-8 production by PIE cells in response to heat-stable ETEC PAMPs or LPS challenges . For these reasons, we first focused on L. jensenii TL2937 to evaluate its anti-inflammatory effect in BIE cells. L. jensenii TL2937 is able to decrease IL-6 (20% lower than control) and IL-8 (25% lower than control) expressions in heat-stable ETEC PAMPs-challenged BIE cells. However, this effect was lower when compared with the immunomodulatory activity of this strain in porcine IECs . In heat-stable ETEC PAMPs-challenged porcine IECs previously treated with L. jensenii TL2937 the expression of IL-6 and IL-8 were 35% and 30% lower than control respectively . Although the effect of L. jensenii TL2937 in BIE cells was lower than the previously described in porcine IECs, the present study indicate that LAB strains could be beneficial for attenuating inflammatory damage caused by heat-stable ETEC PAMPs in BIE cells. Thus, we next aimed to select the most effective strains of lactobacilli able to modulate heat-stable ETEC PAMPs-mediated inflammatory response in BIE cells. Several strains were evaluated in our system and we found that some lactobacilli were able to down-regulate the expression of inflammatory cytokines. Among these strains, L. casei OLL2768 showed the most pronounced effect. Of interest, we showed that the immunoregulatory effect of L. casei OLL2768 in BIE cells was more pronounced than that observed for L. jensenii TL2937, while the effect of OLL2768 strain was lower in porcine IECs . Then, our findings indicate that is appropriate to evaluate different strains carefully according to the specific host, because the effect of the same LAB strain may differ according to the host that consumes it. In this sense, our in vitro bovine system can be of great value to find immunobiotic LAB strains suitable on the bovine host.
In BIE cells, L. casei OLL2768 attenuated heat-stable ETEC PAMPs-induced pro-inflammatory response and we confirmed that these effects were related to the capacity of OLL2768 strain to inhibit NF-κB and p38 signaling pathways in heat-stable ETEC PAMPs-challenged BIE cells. These results are reminiscent of other studies showing that probiotics are able to suppress TNF- or S. typhimurium- induced IL-8 gene expression and secretion by IECs in a NF-κB-dependent manner [28, 29]. Moreover, our experiments extended these findings by showing that LAB are able to inhibit p38 signaling pathway in heat-stable ETEC PAMPs-challenged bovine IECs.
The JNK and p38 MAPK pathways share several upstream regulators, and accordingly there are multiple stimuli that simultaneously activate both pathways. Then we expected that L. casei OLL2768 had the same effect on JNK as they had in p38 pathway. However, we found an opposite behavior in JNK pathway. While in L. casei OLL2768-treated BIE cells the phosphorylation of p38 was reduced after challenge with heat-stable ETEC PAMPs, increased levels of p-JNK were detected. It was shown that these two stress-activated signaling pathways induce opposite effects and there is evidence indicating that the p38 MAPK pathway can negatively regulate JNK activity in several contexts [30, 31]. In fact, the first evidence for this crosstalk was the observation that chemical inhibition of p38α and p38β strongly increased the activation of JNK, which was induced by IL-1 and sorbitol in epithelial cells and by LPS in macrophages . Moreover, the kinetic analysis of our results showed an up-regulation of p-p38 between 5 and 10 minutes after heat-stable ETEC PAMPs challenge that was followed by a down-regulation of p-JNK between 10 and 20 minutes. Therefore, we can speculate that L. casei OLL2768 has a direct influence in p38 pathway while its effect in JNK is the result of the inhibition of p38 phosphorylation. Further research is needed to clarify completely the influence of L. casei OLL2768 in MAPK pathways in heat-stable ETEC PAMPs-challenged BIE cells.
Regulatory proteins can modulate the duration and intensity of TLRs signals . Consequently, to dissect the mechanism(s) that underlie the anti-inflammatory effect of L. casei OLL2768, we evaluated the effect of this strain on the expression of the TLRs negative regulators in BIE cells. We observed that L. casei OLL2768 can negatively regulate TLR4 signaling in BIE cells by up-regulating Tollip and Bcl-3 proteins. Bcl-3 functions as an inhibitor of NF-κB activity by stabilizing repressive NF-κB homodimers in a DNA-bound state and preventing the binding of transcriptionally active dimers. In fact, stabilization of repressive complexes through the induction of Bcl-3 expression has been proposed to function in the processes of LPS tolerance . On the other hand, it was demonstrated that overexpression of Tollip impairs TLR4-triggered NF-кB and MAPK signaling pathways and that inhibition of TLR signaling by Tollip is mediated through its ability to suppress the activity of IL-1 receptor-associated kinase (IRAK) [34, 35]. Moreover, it was showed that prior exposure of IECs to a TLR ligand, such as LPS, induces a hyporesponsive state to a second challenge with the same or another TLR ligand by selectively limiting pro-inflammatory responses through up-regulation of Tollip and subsequent suppression of IRAK . Therefore, the induction of Bcl-3 and Tollip by L. casei OLL2768 in BIE cells is important in establishing NF-κB- and MAPK-mediated tolerance against heat-stable ETEC PAMPs.
We firstly reported in this study that BIE cells are useful for studying in vitro inflammatory responses in the bovine gut epithelium triggered by activation of TLR4. We also demonstrated that BIE cells can be used for the selection of immunomodulatory LAB and for studying the mechanisms involved in the protective activity of immunobiotics against pathogen-induced inflammatory damage, providing useful information that may be used for the development of new immunologically functional feeds through the screening and precise selection of lactobacilli strains that are able to beneficially modulate the immune system in the bovine host. In addition, we showed that L. casei OLL2768 functionally modulate the bovine intestinal epithelium by attenuating heat-stable ETEC PAMPs-induced NF-κB and MAPK activation and pro-inflammatory cytokines expression. Therefore L. casei OLL2768 is a good candidate for in vivo studying the protective effect of LAB against intestinal inflammatory damage induced by ETEC infection or heat-stable ETEC PAMPs challenge in the bovine host.
Julio Villena: JSPS Postdoctoral Fellowship for Foreign Researchers.
A20-binding inhibitor of nuclear factor kappa B activation 3
B-cell lymphoma 3-encoded protein
- BIE cells:
Bovine intestinal epithelial cell
Dulbecco’s Modified Eagle media
Enterotoxigenic Escherichia coli
Extracellular signal-regulated kinase
General Linear Models
Porcine toll-like receptor 2-expressing transfectant
Interleukin-1 receptor-associated kinase M
Intestinal epithelial cells
Nuclear factor kappa B inhibitor protein
c-Jun N-terminal kinase
Lactic acid bacteria
Mitogen-activated protein kinases
Mitogen-activated protein kinase 1
Nuclear factor kappa B
Synthetic tripalmitoylated lipopeptide Pam3CysSerLys4
Pathogen-associated molecular patterns
Porcine intestinal epithelial
Pattern recognition receptor
Fast Start Universal SYBR Green Master
p38 mitogen-activated protein kinase
Single immunoglobulin IL-1-related receptor
Transforming growth factor β
Tumor necrosis factor
Toll interacting protein
This study was supported by a Grant-in-Aid for Scientific Research (B)(2) (No. 21380164, 24380146) and Challenging Exploratory Research (No. 23658216) from the Japan Society for the Promotion of Science (JSPS), the Kieikai Research Foundation, Japan Racing Association and the Japan Dairy Association (J-milk) to Dr. H. Kitazawa. Dr. Julio Villena was supported by JSPS (Postdoctoral Fellowship for Foreign Researchers, Program No. 21–09335).
- Foster DM, Smith GW: Pathophysiology of diarrhea in calves. Vet Clin North Am Food Anim Pract. 2009, 25: 13-36. 10.1016/j.cvfa.2008.10.013.PubMedView Article
- Zhou C, Liu Z, Jiang J, Yu Y, Zhang Q: Differential gene expression profiling of porcine epithelial cells infected with three enterotoxigenic Escherichia coli strains. BMC Genomics. 2012, 13: 330-10.1186/1471-2164-13-330.PubMedPubMed CentralView Article
- Ondrackova P, Alexa P, Matiasovic P, Volf J, Faldyna M: Interaction of porcine neutrophils with different strains of enterotoxigenic Escherichia coli. Vet Microbiol. 2012, 60: 108-116.View Article
- Geens MM, Niewold TA: Preliminary characterization of the transcriptional response of the porcine intestinal cell line IPEC-J2 to Enterotoxigenic Escherichia coli, Escherichia coli, and E. coli lipopolysaccharide. Comp Funct Genomics. 2010, 469583:
- Berkes J, Viswanathan VK, Savkovic SD, Hecht G: Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut. 2003, 52: 439-451. 10.1136/gut.52.3.439.PubMedPubMed CentralView Article
- FAO/WHO: Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food (FAO/WHO. 2002, London, Canada
- Clancy R: Immunobiotics and the probiotic evolution. FEMS Immunol Med Microbiol. 2003, 38: 9-12. 10.1016/S0928-8244(03)00147-0.PubMedView Article
- Roselli M, Finamore A, Britti MS, Konstantinov SR, Smidt H, de Vos W, Mengheri E: The novel porcine Lactobacillus sobrius strain protects intestinal cells from enterotoxigenic Escherichia coli K88 infection and prevents membrane barrier damage. J Nutr. 2007, 137: 2709-2716.PubMed
- Roselli M, Finamore A, Britti MS, Mengheri E: Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88. Br J Nutr. 2006, 95: 1177-1184. 10.1079/BJN20051681.PubMedView Article
- Zanello G, Meurens F, Berri M, Chevaleyre C, Melo S, Auclair E, Salmon S: Saccharomyces cerevisiae decreases inflammatory responses induced by F4+ enterotoxigenic Escherichia coli in porcine intestinal epithelial cells. Vet Immunol Immunopathol. 2011, 141: 133-138. 10.1016/j.vetimm.2011.01.018.PubMedView Article
- Zanello G, Berri M, Dupont J, Sizaret PY, D'Inca R, Salmon H, Meurens F: Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells. PLoS One. 2011, 6: e18573-10.1371/journal.pone.0018573.PubMedPubMed CentralView Article
- Gaggìa F, Mattarelli P, Biavati B: Probiotics and prebiotics in animal feeding for safe food production. Int J Food Microbiol. 2010, 141: S15-28.PubMedView Article
- Fujie H, Villena J, Tohno M, Morie K, Simazu T, Aso H, Suda Y, Iwabuchi N, Xiao J, Iwatsuki K, Kawai Y, Saito T, Kitazawa H: Toll-like receptor-2 activating bifidobacteria strains differentially regulate inflammatory cytokines in porcine intestinal epithelial cell culture system: finding new anti-inflammatory immunobiotics. FEMS Immunol Med Microbiol. 2011, 63: 129-139. 10.1111/j.1574-695X.2011.00837.x.PubMedView Article
- Shimazu T, Villena J, Tohno M, Fujie H, Hosoya S, Shimosato T, Aso H, Suda Y, Kawai Y, Saito T, Makino S, Ikegami S, Itoh H, Kitazawa H: Immunobiotic Lactobacillus jensenii elicit anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the toll-like receptor signaling pathway. Infect Immun. 2012, 80: 276-288. 10.1128/IAI.05729-11.PubMedPubMed CentralView Article
- Villena J, Suzuki R, Fujie H, Chiba E, Takahashi T, Shimazu T, Aso H, Ohwada S, Suda Y, Ikegami S, Itoh H, Alvarez S, Saito T, Kitazawa H: Immunobiotic Lactobacillus jensenii modulates toll-like receptor 4-induced inflammatory response via negative regulation in porcine antigen presenting cells. Clin Vaccine Immunol. 2012, 19: 1038-1053. 10.1128/CVI.00199-12.PubMedPubMed CentralView Article
- Maldonado NC: Silva de Ruiz C, Otero MC, Sesma F, Nader-Macías ME: Lactic acid bacteria isolated from young calves – Characterization and potential as probiotics. Res Vet Sci. 2012, 92: 342-349. 10.1016/j.rvsc.2011.03.017.PubMedView Article
- Miyazawa K, Hondo T, Kanaya T, Tanaka S, Takakura I, Itani W, Rose MT, Kitazawa H, Yamaguchi T, Aso H: Characterization of newly established bovine intestinal epithelial cell line. Histochem Cell Biol. 2010, 133: 125-134. 10.1007/s00418-009-0648-3.PubMedView Article
- Moue M, Tohno M, Shimazu T, Kido T, Aso H, Saito T, Kitazawa H: Toll-like receptor 4 and cytokine expression involved in functional immune response in an originally established porcine intestinal epitheliocyte cell line. Biochim Biophys Acta. 2008, 1780: 134-144. 10.1016/j.bbagen.2007.11.006.PubMedView Article
- Yamamoto T, Nakazawa M: Detection and sequences of the enteroaggregative Escherichia coli heat-stable enterotoxin 1 gene in enterotoxigenic E. coli strains isolated from piglets and calves with diarrhea. J Clin. Microbiol. 1997, 35: 223-227.PubMedPubMed Central
- Wells JM, Rossi O, Meijerink M, van Baarlen P: Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci USA. 2011, 108: 4607-4614. 10.1073/pnas.1000092107.PubMedPubMed CentralView Article
- Lee JD, Mo JH, Shen C, Rucker AN, Raz E: Toll-like receptor signaling in intestinal epithelial cells contributes to colonic homoeostasis. Curr Opin Gastroenterol. 2007, 23: 27-31. 10.1097/MOG.0b013e3280118272.PubMedView Article
- Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK: Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol. 2000, 164: 966-972.PubMedView Article
- Sitaraman SV, Merlin D, Wang L, Wong M, Gewirtz AT, Si-Tahar M, Madara JL: Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J Clin Invest. 2001, 107: 861-869. 10.1172/JCI11783.PubMedPubMed CentralView Article
- Warhurst AC, Hopkins SJ, Warhurst G: Interferon gamma induces differential up-regulation of alpha and beta chemokine secretion in colonic epithelial cell lines. Gut. 1998, 42: 208-213. 10.1136/gut.42.2.208.PubMedPubMed CentralView Article
- Alvarez S, Villena J, Tohno M, Salva S, Kitazawa H: Modulation of innate immunity by lactic acid bacteria: impact on host response to infections. Curr Res Immunol. 2009, 3: 87-126. Research Media (Ed), India
- Salva S, Villena J, Alvarez S: Diferential immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: impact on intestinal and respiratory infections. Int J Food Microbiol. 2010, 141: 82-89. 10.1016/j.ijfoodmicro.2010.03.013.PubMedView Article
- Villena J, Racedo S, Agüero G, Bru E, Medina M, Alvarez S: Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J Nutr. 2005, 135: 1462-1469.PubMed
- O’Hara AM, O’Regan P, Fanning A, Mahony C, Macsharry J, Lyons A, Bienenstock J, O'Mahony F: Shanahan, Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunol. 2006, 118: 202-215. 10.1111/j.1365-2567.2006.02358.x.View Article
- Zhang L, Li N, Caicedo R, Neu J: Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr. 2005, 135: 1752-1756.PubMed
- Cheung PC, Campbell DG, Nebreda AR, Cohen P: Feedback control of the protein kinase TAK1 by SAPK2a/p38α. EMBO J. 2003, 22: 5793-5805. 10.1093/emboj/cdg552.PubMedPubMed CentralView Article
- Muniyappa H, Das KC: Activation of c-Jun N.-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK3–MKK7-dependent mechanism. Cell Signal. 2008, 20: 675-683. 10.1016/j.cellsig.2007.12.003.PubMedPubMed CentralView Article
- Liew FY, Brint XD, EK O, Neill LA: Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol. 2005, 5: 446-458. 10.1038/nri1630.PubMedView Article
- Wessells J, Baer M, Young HA, Claudio E, Brown K, Siebenlist U, Johnson PF: Bcl-3 and NF‐κB p50 attenuate lipopolysaccharide‐induced inflammatory responses in macrophages. J Biol Chem. 2004, 279: 49995-50003. 10.1074/jbc.M404246200.PubMedView Article
- Burns K, Clatworthy J, Martin L, Martinon F, Plumpton C, Maschera B, Lewis A, Ray K, Tschopp J, Volpe F: Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol. 2000, 2: 346-351. 10.1038/35014038.PubMedView Article
- Zhang G, Ghosh S: Negative regulation of toll-like receptor- mediated signaling by Tollip. J Biol Chem. 2002, 277: 7059-7065. 10.1074/jbc.M109537200.PubMedView Article
- Otte JM, Cario E, Podolsky DK: Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterol. 2004, 126: 1054-1070. 10.1053/j.gastro.2004.01.007.View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.